BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37434147)

  • 1. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
    Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
    BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
    Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
    BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity, polypharmacy, and mortality in older patients with pacemakers.
    Goto T; Mori K; Nakayama T; Yamamoto J; Shintani Y; Wakami K; Fukuta H; Seo Y; Ohte N
    J Arrhythm; 2022 Feb; 38(1):145-154. PubMed ID: 35222761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
    Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
    BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study.
    Rogero-Blanco E; Lopez-Rodriguez JA; Sanz-Cuesta T; Aza-Pascual-Salcedo M; Bujalance-Zafra MJ; Cura-Gonzalez I;
    JMIR Med Inform; 2020 Mar; 8(3):e14130. PubMed ID: 32149715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-sectional Study.
    Rogero-Blanco E; López-Rodríguez JA; Sanz-Cuesta T; Aza-Pascual-Salcedo M; Bujalance-Zafra MJ; Cura-González I;
    JMIR Med Inform; 2020 Mar; 8(2):e14130. PubMed ID: 32126005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.
    Sallevelt BTGM; Huibers CJA; Heij JMJO; Egberts TCG; van Puijenbroek EP; Shen Z; Spruit MR; Jungo KT; Rodondi N; Dalleur O; Spinewine A; Jennings E; O'Mahony D; Wilting I; Knol W
    Drugs Aging; 2022 Jan; 39(1):59-73. PubMed ID: 34877629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
    Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
    Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation.
    Kotalczyk A; Guo Y; Wang Y; Lip GYH; On Behalf Of The ChiOTEAF Registry Investigators
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator.
    Assari S; Wisseh C; Bazargan M
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31226752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
    Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
    Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study.
    Jungo KT; Cheval B; Sieber S; Antonia van der Linden BW; Ihle A; Carmeli C; Chiolero A; Streit S; Cullati S
    PLoS One; 2022; 17(8):e0271298. PubMed ID: 35917337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and potentially inappropriate medications among elderly patients in the geriatric department at a single-center in China: A retrospective cross-sectional study.
    Tao L; Qu X; Gao H; Zhai J; Zhang Y; Song Y
    Medicine (Baltimore); 2021 Oct; 100(42):e27494. PubMed ID: 34678882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an Integrated Ambulatory Care Program in Health Care and Medication Use in Patients With Multimorbidity and Polypharmacy.
    Lo YT; Chen MH; Chen PH; Lu FH; Chang CM; Yang YC
    Qual Manag Health Care; 2024 Jan-Mar 01; 33(1):18-28. PubMed ID: 37752634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
    Jungo KT; Streit S; Lauffenburger JC
    BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study.
    Whitney DG; Schmidt M; Peterson MD; Haapala H
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1153-1161. PubMed ID: 32857655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and factors associated with potentially inappropriate medication use in Chinese older outpatients with cancer with multimorbidity.
    Tian F; Yang R; Chen Z; Duan X; Yuan P
    J Geriatr Oncol; 2022 Jun; 13(5):629-634. PubMed ID: 35183489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study.
    Liu J; Yu Y; Yan S; Zeng Y; Su S; He T; Wang Z; Ding Q; Zhang R; Li W; Wang X; Zhang L; Yue X
    BMC Geriatr; 2023 Feb; 23(1):75. PubMed ID: 36740694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.